Consensus of experts from the Russian Society of Cardiology, the Russian Endocrinology Association, and the Russian Phlebology Association on medication adherence in chronic diseases
G. R. Galstyan,
I. I. Dedov,
I. A. Zolotukhin,
A. O. Konradi,
A. O. Nedoshivin,
I. A. Suchkov,
M. V. Shestakova,
E. V. Shlyakhto https://doi.org/10.15829/1560-4071-2025-6676
EDN: GWEUFG
Abstract
The expert consensus proposes a potential program of action to address the problem of low medication adherence in asymptomatic chronic diseases. The experts recognize adherence as a key factor in the success of chronic disease treatment and consider improving adherence as one of the strategic objectives of all programs to reduce mortality and the overall burden of chronic diseases.
Keywords
Supporting agencies: The article was published with the support of the Servier company.
About the Authors
G. R. Galstyan
Dedov National Medical Research Center of Endocrinology
Russian Federation
Competing Interests:
Russian Federation
Dmitry Ulyanov str., 11, Moscow
Competing Interests:
None
I. I. Dedov
Dedov National Medical Research Center of Endocrinology
Russian Federation
Competing Interests:
Russian Federation
Dmitry Ulyanov str., 11, Moscow
Competing Interests:
None
I. A. Zolotukhin
Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Ostrovityanova str., 1, building 7, Moscow
Competing Interests:
None
A. O. Konradi
Almazov National Medical Research Center
Russian Federation
Competing Interests:
Russian Federation
Akkuratov St., 2, Saint Petersburg
Competing Interests:
None
A. O. Nedoshivin
Almazov National Medical Research Center
Russian Federation
Competing Interests:
Russian Federation
Akkuratov St., 2, Saint Petersburg
Competing Interests:
None
I. A. Suchkov
Pavlov Ryazan State Medical University
Russian Federation
Competing Interests:
Russian Federation
Vysokovoltnaya St., 9, Ryazan
Competing Interests:
None
M. V. Shestakova
Dedov National Medical Research Center of Endocrinology
Russian Federation
Competing Interests:
Russian Federation
Dmitry Ulyanov str., 11, Moscow
Competing Interests:
None
E. V. Shlyakhto
Almazov National Medical Research Center
Russian Federation
Competing Interests:
Russian Federation
Akkuratov St., 2, Saint Petersburg
Competing Interests:
None
References
1. Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018;22:18-033. doi:10.7812/TPP/18-033.
2. Vandenberghe D, Albrecht J. The financial burden of non-communicable diseases in the European Union: a systematic review. Eur J Public Health. 2020;30(4):833-9. doi:10.1093/eurpub/ckz073.
3. Parati G, Goncalves A, Soergel D, et al. New perspectives for hypertension management: progress in methodological and technological developments. Eur J Prev Cardiol. 2023;30:48-60. doi:10.1093/eurjpc/zwac203.
4. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882-7.e1. doi:10.1016/j.amjmed.2011.12.013.
5. Chang TE, Ritchey MD, Park S, et al. National rates of nonadherence to antihypertensive medications among insured adults with hypertension, 2015. Hypertension. 2019;74:1324-32. doi:10.1161/hypertensionaha.119.13616.
6. Qvarnström M, Kahan T, Kieler H, et al. Persistence to antihypertensive drug treatment in Swedish primary healthcare. Eur J Clin Pharmacol. 2013;69:1955-64. doi:10.1007/s00228-013-1555-z.
7. Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124:1124-40. doi:10.1161/circresaha.118.313220.
8. Curneen JMG, Rabbitt L, Browne D, et al. Major disparities in patient-reported adherence compared to objective assessment of adherence using mass spectrometry: a prospective study in a tertiary-referral hypertension clinic. Br J Clin Pharmacol. 2022;89:1948-55. doi:10.1111/bcp.15292.
9. Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29:610-8. doi:10.1097/HJH.0b013e328342ca97.
10. Kim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67:506-12. doi:10.1161/hypertensionaha.115.06731.
11. Kirienko AI, Zolotukhin IA, Iumin SM, Seliverstov EI. The Effectiveness of Specialized Phlebological Care in Russia: the Results of the Prospective Observational Study SPECTRUM. Journal of Venous Disorders. 2015;9(2):4-11. (In Russ.) doi:10.17116/flebo2015924-11.
12. Lane D, Lawson A, Burns A, et al. Nonadherence in hypertension: how to develop and implement chemical adherence testing. Hypertension. 2022;79:12-23. doi:10.1161/hypertensionaha.121.17596.
13. Bergland OU, Halvorsen LV, Søraas CL, et al. Detection of nonadherence to antihypertensive treatment by measurements of serum drug concentrations. Hypertension. 2021;78:617-28. doi:10.1161/hypertensionaha.121.17514.
14. McEvoy JW, McCarthy CP, Bruno RM, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. doi:10.1093/eurheartj/ehae178. Erratum in: Eur Heart J. 2025;46(14):1300. doi:10.1093/eurheartj/ehaf031.
15. Kalinina AM, Oganov RG, Nebieridze DV. Patients education as a factor for arterial hypertension effective control — NOCTURNE program. Cardiovascular Therapy and Prevention. 2006;5(3):5-14. (In Russ.) EDN: ISVXFT.
16. Liao Y, Gao G, Peng Y. The effect of goal setting in asthma self-management education: A systematic review. Int J Nurs Sci. 2019;6(3):334-42. doi:10.1016/j.ijnss.2019.04.003.
17. Dodd KE, Mazurek JM. Asthma self-management education in persons with work-related asthma — United States, 2012-2014. J Asthma. 2020;57(6):593-600. doi:10.1080/02770903.2019.1594890.
18. Andreev AN, Izmozherova NV, Kolotova GB, et al. "School of Health" for arterial hypertension patients: district out-patient clinic experience. Cardiovascular Therapy and Prevention. 2006;5(3):15-21. (In Russ.) EDN: ISVXGD.
19. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115. doi:10.1161/HYP.0000000000000065.
20. Starostina EG, Antsiferov MB. Diabetes education in the USSR: how to begin? Diabet Med. 1990;7(8):744-9. doi:10.1111/j.1464-5491.1990.tb01480.x.
21. Starostina EG, Antsiferov M, Galstyan GR, et al. Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow — blood glucose versus urine glucose self-monitoring. Diabetologia. 1994;37(2):170-6. doi:10.1007/s001250050089.
22. Starostina EG, Antsiferov MB, Galstyan GR, Dedov II. Effectiveness of the intensive treatment and education program for patients with type 1 diabetes mellitus. Problems of endocrinology. 1994;40(3):15-9. (In Russ.)
23. Galstyan GR, Mayorov AYu, Dvoinishikova OM, et al. Long-term results of therapeutic education in patients with type 1 diabetes mellitus. Problems of endocrinology. 2005;51(3):50-5. (In Russ.)
24. Surkova EV, Antsiferov MB. The role of training programs in the treatment of patients with type II diabetes mellitus. Problems of endocrinology. 1995;41(6):4-6. (In Russ.)
25. Correia JC, Waqas A, Aujoulat I, et al. Evolution of Therapeutic Patient Education: A Systematic Scoping Review and Scientometric Analysis. Int J Environ Res Public Health. 2022;19(10):6128. doi:10.3390/ijerph19106128.
26. Woolley AK, Hadjiconstantinou M, Davies M, et al. Online patient education interventions in type 2 diabetes or cardiovascular disease: A systematic review of systematic reviews. Prim Care Diabetes. 2019;13(1):16-27. doi:10.1016/j.pcd.2018.07.011.
27. Ionov MV, Zhukova OV, Zvartau NE, Konradi AO. Telemedicine monitoring and remote counseling of patients with uncontrolled arterial hypertension. Therapeutic Archive. 2021;93(1):30-40. (In Russ.)
28. Nkhoma DE, Soko CJ, Bowrin P, et al. Digital interventions self-management education for type 1 and 2 diabetes: A systematic review and meta-analysis. Comput Methods Programs Biomed. 2021;210:106370. doi:10.1016/j.cmpb.2021.106370.
29. Laufs U, Rettig-Ewen V, Böhm M. Strategies to improve drug adherence. Eur Heart J. 2011;32(3):264-8. doi:10.1093/eurheartj/ehq297.
30. Borghi C, Balagopalan Jayagopal P, Konradi A, et al. A Real-World Analysis of Pharmaco-Utilization and Outcomes of Patients on Perindopril/Amlodipine/Indapamide Free Vs Single-Pill Combination in Italy. Journal of Hypertension. 2023;41(Suppl 1):p e310. doi:10.1097/01.hjh.0000915900.31195.ab.
31. Snyman JR, Balagopalan Jayagopal P, Konradi A, et al. EE478 Do Triple Single-Pill Combinations Make a Difference in Treatment Adherence, Outcomes and Healthcare Resource Utilization in Hypertension? A Real-World Analysis of Patients on Perindopril/ Amlodipine/Indapamide in Italy. Value in Health. 2022;25(12):S149. doi:10.1016/j.jval.2022.09.721.
32. Liao CT, Toh HS, Sun L, et al. Cost-effectiveness of intensive vs standard blood pressure control among older patients with hypertension. JAMA Netw Open. 2023;6:e230708. doi:10.1001/jamanetworkopen.2023.0708.
Review
For citations:
Galstyan G.R., Dedov I.I., Zolotukhin I.A., Konradi A.O., Nedoshivin A.O., Suchkov I.A., Shestakova M.V., Shlyakhto E.V. Consensus of experts from the Russian Society of Cardiology, the Russian Endocrinology Association, and the Russian Phlebology Association on medication adherence in chronic diseases. Russian Journal of Cardiology. 2025;30(11):6676. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6676. EDN: GWEUFG
Views:
508
JATS XML
Email this article 